Production of 3-N-[11C]methylspiperone with high specific activity and high radiochemical purity for PET studies: suppression of its radiolysis. 1990

K Suzuki, and O Inoue, and K Tamate, and F Mikado
Section of Cyclotron, National Institute of Radiological Sciences, Chiba, Japan.

3-N-[11C]methylspiperone(11C-NMS, molecular weight = 409 for 12C-NMS) has been prepared automatically with high specific activity (37 +/- 18 GBq/mumol at EOS) for the measurement of dopamine D2 receptors in the human brain with a positron camera. It was observed that the radiochemical purity of 11C-NMS decreased from 97.8% (in HPLC eluate) to 83.5% (in saline, after the dispensing procedure, at 29 min from EOS), and to 79.9% in a further 59 min and that another 11C-labelled compound with a molecular weight of 425 (as a 12C-labelled compound) was formed. It was also observed that an aqueous solution of carrier methylspiperone (NMS) decomposed on 60Co irradiation and, using the same analytical conditions, gave the compound with the same retention time and the same molecular weight as 11C-NMS gave. The G-value of NMS decomposition by 60Co irradiation was estimated to be about two in an aqueous solution. The decomposition of 11C-NMS was suppressed remarkably by the addition of hydroxyl radical scavengers such as potassium iodide, and accelerated slightly by a hydrated electron scavenger such as sodium nitrate. Therefore, it was assumed that the hydroxyl radical generated by the radiolysis of water played an important role in the decomposition of 11C-NMS in the aqueous solution. Polysolvate-80 and ethyl alcohol were used as i.v. injectable additives to protect 11C-NMS against decomposition. In 47 routine productions, 2.7 +/- 1.7 GBq of 11C-NMS aqueous solutions ready for i.v. injection have been produced at 98.3 +/- 1.0% radiochemical purity using an automated synthesis apparatus. The products were used for clinical purposes with a positron camera and animal experiments.

UI MeSH Term Description Entries
D007553 Isotope Labeling Techniques for labeling a substance with a stable or radioactive isotope. It is not used for articles involving labeled substances unless the methods of labeling are substantively discussed. Tracers that may be labeled include chemical substances, cells, or microorganisms. Isotope Labeling, Stable,Isotope-Coded Affinity Tagging,Isotopically-Coded Affinity Tagging,Affinity Tagging, Isotope-Coded,Affinity Tagging, Isotopically-Coded,Isotope Coded Affinity Tagging,Labeling, Isotope,Labeling, Stable Isotope,Stable Isotope Labeling,Tagging, Isotope-Coded Affinity,Tagging, Isotopically-Coded Affinity
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013134 Spiperone A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA. Spiroperidol,Spiroperone
D014055 Tomography, Emission-Computed Tomography using radioactive emissions from injected RADIONUCLIDES and computer ALGORITHMS to reconstruct an image. CAT Scan, Radionuclide,CT Scan, Radionuclide,Computerized Emission Tomography,Radionuclide Tomography, Computed,Scintigraphy, Computed Tomographic,Tomography, Radionuclide-Computed,Computed Tomographic Scintigraphy,Emission-Computed Tomography,Radionuclide Computer-Assisted Tomography,Radionuclide Computerized Tomography,Radionuclide-Computed Tomography,Radionuclide-Emission Computed Tomography,Tomography, Computerized Emission,CAT Scans, Radionuclide,CT Scans, Radionuclide,Computed Radionuclide Tomography,Computed Tomography, Radionuclide-Emission,Computer-Assisted Tomographies, Radionuclide,Computer-Assisted Tomography, Radionuclide,Computerized Tomography, Radionuclide,Emission Computed Tomography,Emission Tomography, Computerized,Radionuclide CAT Scan,Radionuclide CAT Scans,Radionuclide CT Scan,Radionuclide CT Scans,Radionuclide Computed Tomography,Radionuclide Computer Assisted Tomography,Radionuclide Computer-Assisted Tomographies,Radionuclide Emission Computed Tomography,Scan, Radionuclide CAT,Scan, Radionuclide CT,Scans, Radionuclide CAT,Scans, Radionuclide CT,Tomographic Scintigraphy, Computed,Tomographies, Radionuclide Computer-Assisted,Tomography, Computed Radionuclide,Tomography, Emission Computed,Tomography, Radionuclide Computed,Tomography, Radionuclide Computer-Assisted,Tomography, Radionuclide Computerized,Tomography, Radionuclide-Emission Computed
D015259 Dopamine Agents Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons. Dopamine Drugs,Dopamine Effect,Dopamine Effects,Dopaminergic Agents,Dopaminergic Drugs,Dopaminergic Effect,Dopaminergic Effects,Agents, Dopamine,Agents, Dopaminergic,Drugs, Dopamine,Drugs, Dopaminergic,Effect, Dopamine,Effect, Dopaminergic,Effects, Dopamine,Effects, Dopaminergic
D017448 Receptors, Dopamine D2 A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D2-class receptor genes contain INTRONS, and the receptors inhibit ADENYLYL CYCLASES. Dopamine D2 Receptors,Dopamine-D2 Receptor,D2 Receptors, Dopamine,Dopamine D2 Receptor,Receptor, Dopamine-D2

Related Publications

K Suzuki, and O Inoue, and K Tamate, and F Mikado
January 1986, Journal of computer assisted tomography,
K Suzuki, and O Inoue, and K Tamate, and F Mikado
January 1986, European journal of nuclear medicine,
K Suzuki, and O Inoue, and K Tamate, and F Mikado
June 1999, Annals of nuclear medicine,
K Suzuki, and O Inoue, and K Tamate, and F Mikado
November 1993, Nuclear medicine and biology,
K Suzuki, and O Inoue, and K Tamate, and F Mikado
January 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
K Suzuki, and O Inoue, and K Tamate, and F Mikado
September 1985, The International journal of applied radiation and isotopes,
K Suzuki, and O Inoue, and K Tamate, and F Mikado
January 2009, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine,
K Suzuki, and O Inoue, and K Tamate, and F Mikado
April 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Copied contents to your clipboard!